ASTRAZENECA PHARMACEUTICALS LP et al v. SANDOZ INC. > Summary
Court Case Number 3:24-cv-00641
Filing Date Feb 2, 2024
Court New Jersey District Court
Status Unknown
JudgesRobert Kirsch
Plaintiff
4Defendant
Plaintiff Attorneys
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
Defendant Attorneys
2Sandoz
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Sandoz
Attorney Name: William P. Murtha Jr.
Hill Wallack LLP
Counter Defendant
10The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
The University of Sheffield
Attorney Name: Charles H. Chevalier
Gibbons P.C.
Counter Claimant
4Sandoz
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Sandoz
Attorney Name: William P. Murtha Jr.
Sandoz
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Sandoz
Attorney Name: William P. Murtha Jr.
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11633396 | Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one | Apr 25, 2023 |
| 08859562 | Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer | Oct 14, 2014 |
| 08475842 | Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one | Jul 2, 2013 |
| 07449464 | Phthalazinone derivatives | Nov 11, 2008 |
